Cancer Genetics Says Rob Fannon Joins As Vice President Of Operations

(RTTNews) - Cancer Genetics, Inc. (CGIX), involved in DNA-based cancer diagnostics, said Rob Fannon has joined the company as vice president of operations in the Raleigh/Research Triangle Park or RTP, North Carolina location.

Fannon was previously with Roche Molecular's BioSpecimen Management division. He brings more than 10 years of operations, client management, molecular test and panel development, and biorepository management experience to CGI.

At Roche Molecular Systems, Fannon oversaw biospecimen acquisition, panel production, project management, and client relations.

Prior to his tenure at Roche, Fannon served as clinical operations manager at BioServe Biotechnologies, Ltd., being responsible for sales, business development, and client relations.

From 2006 to 2010, he served as an editor and analyst at Stansberry and Associates Investment Research, where he set up an investment advisory publication focused on investment opportunities in publicly-traded biotech, life science, and healthcare companies.